- Report
- October 2025
- 182 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- August 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,485GBP
- Report
- December 2025
- 279 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- August 2025
- 148 Pages
Global
From €2264EUR$2,549USD£1,978GBP
€2664EUR$2,999USD£2,327GBP
- Report
- September 2025
- 150 Pages
Global
From €3419EUR$3,850USD£2,988GBP
- Report
- October 2025
- 160 Pages
Global
From €3508EUR$3,950USD£3,066GBP
- Report
- December 2024
- 120 Pages
Global
From €5284EUR$5,950USD£4,618GBP
- Report
- September 2024
- 100 Pages
Global
From €5284EUR$5,950USD£4,618GBP
- Report
- February 2024
- 120 Pages
Global
From €4219EUR$4,750USD£3,686GBP
- Report
- October 2023
- 140 Pages
Middle East, Africa
From €3553EUR$4,000USD£3,104GBP
- Report
- April 2024
- 283 Pages
Global
From €3197EUR$3,600USD£2,794GBP
- Report
- April 2024
- 143 Pages
Global
From €3500EUR$4,222USD£3,165GBP

The Foot and Mouth Disease (FMD) Vaccines market is a segment of the Animal Pharmaceuticals industry. FMD is a highly contagious viral disease that affects cloven-hoofed animals, such as cattle, sheep, goats, and pigs. Vaccines are used to protect animals from the disease, and the FMD Vaccines market is composed of companies that produce and distribute these vaccines. Vaccines are typically administered through injection, and may be used to prevent outbreaks or to control existing outbreaks.
The FMD Vaccines market is highly competitive, with a number of companies offering a variety of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Sante Animale. Show Less Read more